Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to five years
Awards & highlights
Summary
This trial is testing a new cancer vaccine to see if it can prevent cancer recurrence.
Eligible Conditions
- Colon Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to five years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to five years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Disease-Free Survival
Secondary study objectives
Overall Survival
Recurrence-Free Interval
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OncoVAX and SurgeryExperimental Treatment2 Interventions
Autologous Specific Immunotherapy given intradermally following surgical resection of Stage II colon cancer
Group II: SurgeryActive Control1 Intervention
Surgical resection of Stage II colon cancer
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Surgery
2000
Completed Phase 3
~2490
Find a Location
Who is running the clinical trial?
Vaccinogen IncLead Sponsor
Rachel L Hoover, MS, MBAStudy DirectorVaccinogen Inc
Michael G Hanna, Jr, PhDStudy ChairVaccinogen Inc
Share this study with friends
Copy Link
Messenger